Diltiazem and Digoxin: Interaction Details
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Diltiazem and Digoxin interaction:
Diltiazem
- Cardizem
- Cardizem CD
- Cardizem LA
- Cartia XT
- Dilacor XR
- Dilt-CD
- Diltzac
- Taztia XT
- Tiazac
- Cardizem SR
- Tiamate
- Matzim
- Tiadylt
- Taztia
- Cartia
Digoxin
- Cardoxin
- Digitek
- Lanoxicaps
- Lanoxin
- Digox
What Happens When You Take Diltiazem With Digoxin
What can happen when they are taken together (rated Major)
Increased digoxin exposure and an increased risk of and advanced complete heart block
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving digoxin together with dilTIAZem (a and calcium channel blocker) can raise digoxin exposure. The two drugs may also have effects on AV node conduction, which can lead to bradycardia and advanced or complete heart block.
Digoxin exposure should be measured before the drugs are started. To lower digoxin concentrations, reduce the dose by roughly 15-30% or change the dosing frequency, and keep monitoring. Watch as well for potential signs and symptoms of clinical toxicity23 when dilTIAZem therapy is started, adjusted, or stopped, so that over- or under-digitalization can be avoided.1
The Diltiazem and Digoxin Interaction, Explained
Diltiazem can raise the amount of digoxin in your body. It slows the pump that normally helps clear digoxin out, so digoxin levels can climb. Both medicines also slow the electrical signals in your heart. Together, this can make your heartbeat too slow and, in serious cases, can block signals between the upper and lower parts of the heart.
Watch for a very slow pulse, dizziness, fainting, unusual tiredness, nausea, vomiting, or vision changes. Digoxin has a narrow safety range, so small changes matter. Your care team can manage this by checking your digoxin level and adjusting your dose. Please keep taking both as prescribed and talk with your pharmacist or doctor about any symptoms.
Mechanism: Diltiazem inhibits -mediated efflux of digoxin, increasing digoxin exposure, with negative dromotropic and chronotropic effects at the AV node (PK and PD). Digoxin is a narrow-therapeutic-index drug, so modest rises in exposure are clinically relevant.
- Risk: , advanced or complete heart block, digoxin toxicity.
- Onset: rapid. Severity: major. Evidence: probable.
- Management: measure digoxin concentration before starting diltiazem; consider reducing the digoxin dose by about 15-30% or adjusting the dosing frequency; continue monitoring.
- Monitor for signs of toxicity and for heart rate and AV conduction when starting, adjusting, or stopping diltiazem, to avoid over- or under-digitalization.
See the 8 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Diltiazem and Digoxin Interact
The likely mechanism
of -mediated efflux transport of digoxin; effects on AV node conduction
How to Manage the Diltiazem and Digoxin Interaction
Your care team can manage this combination by tailoring your doses and monitoring you.
- Your digoxin level may be checked before diltiazem is started.
- Your digoxin dose or how often you take it may need to be adjusted and individualized by your care team (a reduction of roughly 15-30% is often considered).
- Your team may monitor you more closely, including when diltiazem is started, changed, or stopped, since stopping it can also change your digoxin level.
What you can do: keep taking both medicines as prescribed and do not change doses on your own. Tell your pharmacist or doctor right away about a slow heartbeat, dizziness, fainting, nausea, vomiting, or vision changes.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Diltiazem or Digoxin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
6 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: LANOXIN oral tablets, digoxin oral tablets
-
Report 2 · Study title
The influence of diltiazem hydrochloride on trough serum digoxin concentrations
Concurrent dilTIAZem use was associated with a decrease in digoxin . Eight volunteers took oral digoxin 0.25 mg/day alone for 13 days; on day 14, dilTIAZem 30 mg four times daily was added and both drugs were continued for 15 more days.
Trough blood samples were collected throughout the study to measure digoxin concentrations. After the digoxin dose on days 13 and 28, urine was collected for 24 hours.
Adding dilTIAZem significantly raised the mean steady-state digoxin trough concentration from 0.32 to 0.48 nanogram (ng/mL; 0.41 to 0.615 nanomol/L). Digoxin concentrations were elevated in seven subjects, with one showing an increase of 0.3 mg/mL (0.38 mmol/L).
The elevations became apparent within one week of combined therapy. Mean renal clearance fell significantly from 223 to 153 mL/min.
CrCl did not differ between the two phases in these subjects. Because digoxin renal clearance decreased while creatinine clearance stayed constant, the authors attributed the interaction to reduced tubular secretion. However, measuring only trough concentrations does not permit full determination of total body clearance and Vd, which would allow a better analysis.4
-
Report 3 · Study title
Diltiazem increases steady state digoxin serum levels in patients with cardiac disease
The effect of dilTIAZem on steady-state digoxin concentrations was examined in 11 patients with congestive heart failure. All were on a chronic stable oral digoxin dose (nine on 0.25 mg and two on 0.125 mg) for at least 14 days.
Before dilTIAZem (60 mg three times daily) was started, blood samples were drawn immediately before and 3, 6, and 24 hours after a digoxin dose. The same sampling was repeated after 3 days of concurrent dilTIAZem.
In addition, digoxin trough samples were collected after the first and seventh digoxin doses during combined therapy. A significant 36% increase in digoxin concentration was seen on the third day of concurrent therapy.
Trough concentrations rose significantly from 1.1 nanogram/mL (ng/mL; 1.41 nanomol/L) on digoxin alone to 1.5 ng/mL (1.92 nanomol/L) on the seventh day of combined therapy. No patient showed digoxin toxicity. The authors concluded that dilTIAZem and digoxin interact, but that the interaction is of minor clinical importance unless digoxin concentrations are initially at the upper limit of normal.5
-
Report 4 · Study title
Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease
Not every investigator has found digoxin concentrations to rise when dilTIAZem is added. Nine patients with organic heart disease (five with congestive heart failure (CHF) and four with atrial fibrillation), all taking chronic oral digoxin 0.25 mg daily, were studied.
Before dilTIAZem, a 24-hour urine collection and a mid-interval blood sample were obtained. The patients then received dilTIAZem 30 mg four times daily for 4 to 11 days (mean 7 days), after which the dose was increased to 60 mg four times daily for a further 5 to 20 days (mean 11 days).
Blood and urine were collected for digoxin analysis at each dilTIAZem dose. Neither dilTIAZem phase produced a significant change in mean midpoint digoxin concentrations or in digoxin .
Only one patient had a clinically significant increase in digoxin concentration. The authors concluded that there is no interaction between digoxin and dilTIAZem.6
-
Report 5 · Study title
No increase in serum digoxin concentration with high-dose diltiazem
No change in digoxin trough concentrations was reported after concurrent administration of several dilTIAZem doses. Eight subjects received digoxin 0.25 mg for one week, and a trough blood sample was then taken.
DilTIAZem 30 mg four times daily was coadministered for seven days before a second trough sample was drawn. The same procedure was repeated with dilTIAZem 60 mg four times daily and 90 mg four times daily. Compared with baseline (0.85 nanogram/mL (ng/mL) or 1.088 nanomol/L), no digoxin trough concentration differed significantly after dilTIAZem was added (0.86, 0.84, and 0.90 ng/mL or 1.101, 1.076, and 1.152 nanomol/L, respectively).7
-
Report 6 · Study title
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin
The authors of that study were of the opinion that dilTIAZem did not raise digoxin concentrations. Another study may account for the conflicting results among the trials above.
Twelve patients with congestive heart failure, stable for several weeks on an oral dose of beta-acetyldigoxin (0.1 to 0.3 mg daily), were enrolled. Trough blood samples for digoxin determination were taken before dilTIAZem (60 mg three times daily) was started and during dilTIAZem therapy.
In nine patients, urine was collected over 24 hours before and on several occasions during dilTIAZem therapy. Overall, mean digoxin concentrations did not increase with coadministered dilTIAZem.
However, individual data showed that 8 of 12 patients had significant increases in digoxin , ranging from 24% to 70% (mean 46%), with dilTIAZem. In these individuals, total body fell by 28% (oral was assumed to be 80%) while clearance was unchanged, suggesting that the interaction in these patients occurred through nonrenal mechanisms.
Mean total body clearance and renal clearance for the whole study group were not reported. The calculation of digoxin total body clearance and renal clearance in this trial was not optimal because only single trough samples were used.8
Diltiazem and Digoxin: Common Questions
How serious is the Diltiazem and Digoxin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Diltiazem and Digoxin interaction managed?
Your care team can manage this combination by tailoring your doses and monitoring you. Your digoxin level may be checked before diltiazem is started. Your digoxin dose or how often you take it may need to be adjusted and individualized by your care team (a reduction of roughly 15-30% is often considered). Your team may monitor you more closely, including when diltiazem is started, changed, or stop… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Diltiazem and Digoxin Interaction
Ask in your own words about taking Diltiazem and Digoxin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (8)
- Product Information: CARDIZEM(R) oral tablets, diltiazem hydrochloride oral tablets. Bausch Health US LLC (per FDA), Bridgewater, NJ, 2025. DailyMed
- Product Information: LANOXIN(R) oral tablets, digoxin oral tablets. Concordia Pharmaceuticals Inc (per FDA), Kansas City, MO, 2019. DailyMed
- Product Information: DIGOXIN oral tablets, digoxin oral tablets. Aurobindo Pharma USA, Inc. (per Dailymed), East Windsor, NJ, May. DailyMed
- North DS, Mattern AL, & Hiser WW: The influence of diltiazem hydrochloride on trough serum digoxin concentrations. Drug Intell Clin Pharm 1986; 20:500-503. PubMed
- Andrejak M, Hary L, Andrejak MT, et al: Diltiazem increases steady state digoxin serum levels in patients with cardiac disease. J Clin Pharmacol 1987; 27:967-970. PubMed
- Elkayam U, Parikh K, Torkan B, et al: Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease. Am J Cardiol 1985; 55:1393-1395. PubMed
- Boden WE, More G, Sharma S, et al: No increase in serum digoxin concentration with high-dose diltiazem. Am J Med 1986; 81:425-428. PubMed
- Kuhlmann J: Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin. Clin Pharmacol Ther 1985; 37:150-156. PubMed
Other Serious Interactions of Diltiazem and Digoxin
Also serious with Diltiazem
- ColchicineContraindicated
- FlibanserinContraindicated
- LomitapideContraindicated
- Acetaminophen and CodeineMajor
Also serious with Digoxin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Diltiazem
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- American MistletoeMajor
- ColeusMajor
- TyramineMajor
- CalciumModerate
- + 255 more
With Digoxin
- AloeMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Blue FlagMajor
- DanshenMajor
- European BuckthornMajor
- FoxgloveMajor
- Indian SnakerootMajor
- + 106 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.